Patent Expiry

Patent/Exclusivity Expiry: VIVITROL

Other upcoming events for COLL

Phase 2 StartPhase 2 Start: Inpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder: a Randomized Double-blind
Phase 3 ReadoutPhase 3 Topline: Dronabinol and Epidiolex to Manage Uncontrolled Residual Symptoms of Buprenorphine Initiation Trial
Patent ExpiryPatent/Exclusivity Expiry: TROXYCA ER
Patent ExpiryPatent/Exclusivity Expiry: EMBEDA
Patent ExpiryPatent/Exclusivity Expiry: QUILLIVANT XR

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Patent/Exclusivity Expiry: VIVITROL — COLL Patent Expiry | BioSniper